Search results
Lumos Pharma Says Growth Hormone Deficiency Trial Meet Expectations
Benzinga via Yahoo Finance· 1 year agoLumos Pharma Inc (NASDAQ: LUMO) announced interim results from its Phase 2 OraGrowtH210 Trial and...
Why BioMarin Shares Are Plunging Today?
Benzinga via Yahoo Finance· 1 year agoBiomarin Pharmaceutical Inc (NASDAQ: BMRN) shares are falling in reaction to positive data from BridgeBio Pharma Inc's (NASDAQ: BBIO) dwarfism drug,...
BridgeBio Pharma (BBIO) Surges 77% YTD: Here's Why
Zacks via Yahoo Finance· 1 year agoShares of BridgeBio (BBIO) are up rising since the company announced positive data from a mid-stage study, which evaluated its experimental drug...
Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, BMRN was down...
BridgeBio Pharma Touts Encouraging Data From Dwarfism Candidate
Benzinga via Yahoo Finance· 2 years agoBridgeBio Pharma Inc (NASDAQ: BBIO) has announced interim results from PROPEL 2 Phase 2 trial of...
BridgeBio's Dwarfism Candidate Shows Favorable Height Increase, Safety Profile
Benzinga via Yahoo Finance· 1 year agoBridgeBio Pharma Inc (NASDAQ: BBIO) announced results from PROPEL2 Phase 2 trial of infigratinib in...
Why BridgeBio Pharma Stock Is Skyrocketing Today
Motley Fool· 1 year agoWhat happened Shares of BridgeBio Pharma (NASDAQ: BBIO) were skyrocketing 61.2% higher as of 11:55 a.m. ET on Monday. The huge gain came after the...
My dad's classic Greek soup is perfect for a sick day — and way better than chicken noodle. Here's...
INSIDER via Yahoo News· 1 year agoMy dad's avgolemono soup is perfect for a cold — or a cold night. Here's how to make it.Anneta...
Ascendis Pharma's Program Hits Primary Goal In Children With Short-Limbed Dwarfism
Benzinga via Yahoo Finance· 1 year agoAscendis Pharma A/S (NASDAQ: ASND) has announced positive topline results from the ACcomplisH Phase...
Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoLumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript March 7, 2024 Lumos Pharma, Inc....
